We are live on ! Find out more
KXA

KPCB XVI Associates Portfolio holdings

AUM $225M
1-Year Est. Return 26.26%
This Fund
S&P 500
This Quarter Est. Return
-33.18%
1 Year Est. Return
-26.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$225M
AUM Growth
+$7.35M
Cap. Flow
+$128M
Cap. Flow %
56.92%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LIDR icon
AEye
LIDR
+$128M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 55.86%
2 Technology 33.77%
3 Healthcare 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DM
1
DELISTED
Desktop Metal, Inc.
DM
$125M 55.86%
1,749,615
LIDR icon
2
AEye
LIDR
$56M
$75.8M 33.77%
+462,136
New +$128M
VERA icon
3
Vera Therapeutics
VERA
$2.81B
$23.3M 10.38%
1,343,152

Similar funds

KPCB XVI Associates's Q3 2021 Portfolio in Review

As of Q3 2021, KPCB XVI Associates held 3 positions worth $225M, up 3.4% from $217M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XVI Associates deployed $128M of net new capital in Q3 2021, opening 1 new position. Its largest new stake was AEye: 462,136 shares worth $75.8M.

By sector, the portfolio is most concentrated in Industrials at 56% of assets, down from 93% a quarter earlier, followed by Technology and Healthcare.

  • KPCB XVI Associates's largest Q3 2021 buy was AEye: 462,136 shares worth $75.8M.
  • KPCB XVI Associates's ten largest holdings make up 100% of its $225M portfolio in Q3 2021.
  • KPCB XVI Associates opened 1 new position and closed 0 in Q3 2021.
  • KPCB XVI Associates's portfolio value rose 3.4% quarter-over-quarter to $225M.

Based on KPCB XVI Associates's 13F filing for Q3 2021, filed 25 Oct 2021.